Why did Injective (INJ) hit a 3-month high of $6.70 in early 2026?

Injective (INJ) reached a three-month high of $6.70 following a 13% price surge driven by a new all-time high in staked INJ tokens. This milestone indicates a significant reduction in circulating supply, which, combined with flipping the $6.00 resistance level, has shifted market sentiment into a bullish phase.

Injective (INJ) surged to a three-month high of $6.70 in early 2026, fueled by a 13% price jump and a record-breaking amount of INJ tokens being locked in staking contracts. The rally was primarily triggered by the network reaching a new all-time high (ATH) in staked supply, which effectively removed a large portion of liquid INJ from the market and created a supply-demand imbalance in favor of buyers. By successfully flipping the $6.00 psychological resistance level into a support floor, INJ has cleared a significant technical hurdle that had capped growth for several months.

This price action occurs as the broader 2026 crypto market sees renewed interest in high-performance DeFi infrastructure. The record staking numbers suggest that long-term holders are prioritizing yield and network security over short-term liquidity, a trend often seen before sustained upward trends. For US-based traders, this move signals that Injective is successfully maintaining its position as a leading Cosmos-based application-specific blockchain, even amidst a competitive environment for decentralized exchange (DEX) protocols.

The broader market implications are notable, as the $6.70 level represents a recovery of territory lost during the late 2025 volatility. With the staked INJ ATH acting as a vote of confidence from the community, the network's security is at its strongest point in the project's history. This fundamental strength is attracting institutional attention, particularly from funds looking for ecosystems with high "sticky" capital and low exchange-side liquidity.

Moving forward, investors should closely monitor the $6.00 support level; as long as INJ remains above this mark, the path toward the $7.50 range remains open. Additionally, watch for updates regarding Injective’s 2026 roadmap, as further utility for the INJ token could drive staking numbers even higher, potentially squeezing short-sellers. If the staking trend reverses or if large-scale unstaking occurs, the current momentum could face a sharp correction back toward the mid-$5.00 range.

Editorial method

This report is based on the linked source and is labeled with its publication date, provider, category and market-impact assessment. Market interpretation is informational, not investment advice.